Small‐Molecule‐Mediated Degradation of the Androgen Receptor through Hydrophobic Tagging

Gustafson, Jeffrey L., Neklesa, Taavi K., Cox, Carly S., Roth, Anke G., Buckley, Dennis L., Tae, Hyun Seop, Sundberg, Thomas B., Stagg, D. Blake, Hines, John, McDonnell, Donald P., Norris, John D., Crews, Craig M.·2015·Angewandte Chemie International Edition
DOI 10.1002/anie.201503720

Cited by (216)

Items 101–200 of 216

  1. Recent Progress on Microtubule Degradation Agents
    Chufeng Zhang, Min Zhao, Guan Wang, Yong Li · 2023 · Journal of Medicinal Chemistry
  2. Targeted Protein Degradation in Cancer Therapy via Hydrophobic Polymer-Tagged Nanoparticles
    Seohee Lee, Seonwoo Kang, Won Jong Kim · 2025 · ACS Nano
  3. Targeted Protein Degradation: An Emerging Therapeutic Strategy in Cancer
    Samir H. Barghout · 2020 · Anti-Cancer Agents in Medicinal Chemistry
  4. Hydrophobic Tagging-Induced Degradation of PDEδ in Colon Cancer Cells
    Menglu Guo, Shipeng He, Junfei Cheng, Yu Li, Guoqiang Dong, Chunquan Sheng · 2022 · ACS Medicinal Chemistry Letters
  5. Hydrophobic Tag Tethering Degradation, The Emerging Targeted Protein Degradation Strategy
    Jieke Gao, Jiantao Zhang, Xiaoli Han, Jinming Zhou · 2022 · Current Medicinal Chemistry
  6. Emerging Strategies in Proteolysis-Targeting Chimeras (PROTACs): Highlights from 2022
    T. N. Rekha, Dongyun Shin · 2023 · International Journal of Molecular Sciences
  7. Hydrophobic tagging of small molecules: an overview of the literature and future outlook
    Yang Zhou, Fan Zhou, Shujing Xu, Dazhou Shi, Dang Ding, Shuo Wang, Vasanthanathan Poongavanam, Kai Tang, Xinyong Liu, Peng Zhan · 2024 · Expert Opinion on Drug Discovery
  8. Androgen Receptor-Directed Molecular Conjugates for Targeting Prostate Cancer
    Giovanni Luca Beretta, Nadia Zaffaroni · 2019 · Frontiers in Chemistry
  9. Targeted Protein Degradation of Histone Deacetylases by Hydrophobically Tagged Inhibitors
    Felix Feller, Finn Kristian Hansen · 2023 · ACS Medicinal Chemistry Letters
  10. LPM3770277, a Potent Novel CDK4/6 Degrader, Exerts Antitumor Effect Against Triple-Negative Breast Cancer
    Jiahao Qiu, Xinfa Bai, Wenjing Zhang, Mingxu Ma, Wenyan Wang, Liang Ye, Hongbo Wang, Jingwei Tian, Pengfei Yu · 2022 · Frontiers in Pharmacology
  11. Precision Targets for Intercepting the Lethal Progression of Prostate Cancer: Potential Avenues for Personalized Therapy
    Max Christenson, Chung Seog Song, Yaguang Liu, Bandana Chatterjee · 2022 · Cancers
  12. Supramolecular Click Chemistry for Surface Modification of Quantum Dots Mediated by Cucurbit[7]uril
    Katie McGuire, Suhang He, Jennifer Gracie, Charlotte Bryson, Dazhong Zheng, Alasdair W. Clark, Jesko Koehnke, David J. France, Werner M. Nau, Tung‐Chun Lee et al. · 2023 · ACS Nano
  13. Design and synthesis of novel selective estrogen receptor degradation inducers based on the diphenylheptane skeleton
    Takashi Misawa, Takuma Fujisato, Yasunari Kanda, Nobumichi Ohoka, Takuji Shoda, Momoko Yorioka, Makoto Makishima, Yuko Sekino, Mikihiko Naito, Yosuke Demizu et al. · 2016 · MedChemComm
  14. Targeted Protein Degradation by Chimeric Compounds using Hydrophobic E3 Ligands and Adamantane Moiety
    Takuji Shoda, Nobumichi Ohoka, Genichiro Tsuji, Takuma Fujisato, Hideshi Inoue, Yosuke Demizu, Mikihiko Naito, Masaaki Kurihara · 2020 · Pharmaceuticals
  15. Proteolysis targeting chimera, molecular glue degrader and hydrophobic tag tethering degrader for targeted protein degradation: Mechanisms, strategies and application
    Yutian Pan, Yuanjiang Wang, Shaohua Gou · 2025 · Bioorganic Chemistry
  16. Discovery of HyT‐Based Degraders of CDK9‐Cyclin T1 Complex
    Rongkun Lin, Jie Yang, Ting Liu, Mingyu Wang, Chongrong Ke, Cheng Luo, Jin Huo Lin, Jiacheng Li, Hua Lin · 2023 · Chemistry & Biodiversity
  17. Inducing the Degradation of Disease-Related Proteins Using Heterobifunctional Molecules
    Alexandré Delport, Raymond Hewer · 2019 · Molecules
  18. Targeting Cullin-RING Ubiquitin Ligases and the Applications in PROTACs
    Longyuan Gong, Danrui Cui, Xiufang Xiong, Yongchao Zhao · 2020 · Advances in experimental medicine and biology
  19. Chimera induced protein degradation: PROTACs and beyond
    Lina Yin, Qingzhong Hu · 2020 · European Journal of Medicinal Chemistry
  20. Covalent Destabilizing Degrader of AR and AR-V7 in Androgen-Independent Prostate Cancer Cells
    Charlotte M. Zammit, Cory M. Nadel, Ying Q. Lin, Sajjan Koirala, Elnaz Ahani, Patrick Ryan Potts, Daniel K. Nomura · 2025 · Journal of the American Chemical Society
  21. Discovery of Potent and Selective c-Met Degraders for Hepatocellular Carcinoma Treatment
    Wenjian Min, Huanaoyu Yang, Dawei Wang, Chunling Chen, Yanyin Wang, Yi Hou, Yasheng Zhu, Chengliang Sun, Xiao Wang, Kai Yuan et al. · 2024 · Journal of Medicinal Chemistry
  22. Hypoxia-selective allosteric destabilization of activin receptor-like kinases: A potential therapeutic avenue for prophylaxis of heterotopic ossification
    Guorong Lu, Mary Rose Tandang‐Silvas, Alyssa Dawson, Trenton J. Dawson, Jay Clemens Groppe · 2018 · Bone
  23. Recent Advances in the Design and Development of Anticancer Molecules based on PROTAC Technology
    Zere Mukhamejanova, Yichen Tong, Qi Xiang, Fang Xu, Jiyan Pang · 2020 · Current Medicinal Chemistry
  24. Chemical modulation of transcription factors
    Bianca M. Wiedemann, Jörn Weisner, Daniel Rauh · 2018 · MedChemComm
  25. N-Acetylenethio phthalimides: Sequential linkage for compositional click reaction
    Wen‐Chao Gao, Kai Feng, Jun Tian, Juan Zhang, Honghong Chang, Xuefeng Jiang · 2022 · Chinese Chemical Letters
  26. A one-pot photocatalytic triazole-based linkerology for PROTACs
    Jinhua Liu, Yaqi Deng, Jiabin Yin, Jian Ji, Cong Guan, Xuwen Chen, Xiang Wu, Tong Zhu, Shunying Liu · 2024 · Cell Reports Physical Science
  27. Targeted Protein Degradation
    Nello Mainolfi, Tim Rasmusson · 2017 · Annual reports in medicinal chemistry
  28. Non-Steroidal Androgen Receptor Antagonists and Prostate Cancer: A Survey on Chemical Structures Binding this Fast-Mutating Target
    Claudia Ferroni, Greta Varchi · 2018 · Current Medicinal Chemistry
  29. Perspectives on the Development of First-in-Class Protein Degraders
    Kalyn M. Rambacher, Matthew F. Calabrese, Masaya Yamaguchi · 2021 · Future Medicinal Chemistry
  30. Targeting the Hedgehog pathway with novel Gli1 hydrophobic tagging degraders
    Xiangyang Li, Rui Sun, Hao Wu, Chaonan Zheng, Ya‐Qiu Long · 2023 · Bioorganic Chemistry
  31. Design, Synthesis, and Biological Evaluation of Hydrophobic-Tagged Glutathione Peroxidase 4 (GPX4) Degraders
    Xiaomei Li, Mengdie Hu, Yanping Zhang, Hui Hua, Yujie Sun, Qiuping Xiang, Dongsheng Zhu · 2024 · Bioorganic Chemistry
  32. Spirocyclic dimer SpiD7 activates the unfolded protein response to selectively inhibit growth and induce apoptosis of cancer cells
    Smit Kour, Sandeep Rana, Sydney P. Kubica, Smitha Kizhake, Mudassier Ahmad, Catalina Muñoz-Trujillo, David L. Klinkebiel, Sarbjit Singh, Jayapal Reddy Mallareddy, Surabhi Chandra et al. · 2022 · Journal of Biological Chemistry
  33. Synthesis of 3-adamantylated hydantoins and their 2-thio(seleno) analogs
    В. В. Бурмистров, Д. А. Питушкин, V.V. Vasipov, Vladimir S. D’yachenko, Gennady M. Butov · 2019 · Chemistry of Heterocyclic Compounds
  34. A critical update on the strategies towards modulators targeting androgen receptors
    Hongyu Luan, Pengfei Xu, Ying Meng, Zhiyu Li, Jinlei Bian · 2020 · Bioorganic & Medicinal Chemistry
  35. Design, synthesis, and evaluation of the antiproliferative activity of hydantoin-derived antiandrogen-genistein conjugates
    Alex B. George, Idris O. Raji, Bekir Cinar, Ömer Küçük, Adegboyega K. Oyelere · 2018 · Bioorganic & Medicinal Chemistry
  36. Hydrophobic tagging: A promising paradigm for targeted protein degradation
    Lilan Xin, Hongli Wang, Maoze Yang, Zhangxiao Guo, Man Zhu, Terry W. Moore, Chune Dong, Hai‐Bing Zhou · 2025 · Cell Insight
  37. Tunable Linkers for Dynamic Thiol-Based Bioconjugation Strategies
    Gabriele Cianfoni, Luca Pisano, D. M. Varouhaki, G. Centioni, Andrea Calcaterra, Francesca Ghirga, C. M. Athanassopoulos, Bruno Botta, Silvia Cammarone, P. Baiocco et al. · 2026 · Biomacromolecules
  38. A narrative review of proteolytic targeting chimeras (PROTACs): future perspective for prostate cancer therapy
    Xuanrong Chen, Shen Haishan, Yi Shao, Qianwang Ma, Yuanjie Niu, Zhiqun Shang · 2021 · Translational Andrology and Urology
  39. Rational discovery of molecular glue degraders based on block chemistry
    Junjie Wei, Wenjing Feng, Qingsong Chen, Qianbin Li, Zhuo Chen · 2025 · Drug Discovery Today
  40. Lead discovery and chemical biology approaches targeting the ubiquitin proteasome system
    Favour A. Akinjiyan, Seth Carbonneau, Nathan T. Ross · 2017 · Bioorganic & Medicinal Chemistry Letters
  41. Improving Strategies in the Development of Protein‐Downregulation‐Based Antiandrogens
    Rongyu Zhang, Chen‐Chao Huang, Xiaohui Xiao, Jinming Zhou · 2021 · ChemMedChem
  42. PROTACs and Other Chemical Protein Degradation Technologies for the Treatment of Neurodegenerative Disorders
    Shusuke Tomoshige, Minoru Ishikawa · 2020 · Angewandte Chemie
  43. The novel indomethacin derivative CZ-212-3 exerts antitumor effects on castration-resistant prostate cancer by degrading androgen receptor and its variants
    Hong Wang, Zhe Chang, Guodi Cai, Ping Yang, Jiang-he Chen, Shan-shu Yang, Yinfeng Guo, Mingyu Wang, Xuehua Zheng, Jinping Lei et al. · 2021 · Acta Pharmacologica Sinica
  44. Selective degradation of the estrogen receptor in the treatment of cancers
    Zunyuan Wang, Zhen Ma, Zhengrong Shen · 2021 · The Journal of Steroid Biochemistry and Molecular Biology
  45. Structure-based design and synthesis of BML284 derivatives: A novel class of colchicine-site noncovalent tubulin degradation agents
    Chufeng Zhang, Wei Yan, Yan Liu, Minghai Tang, Yaxin Teng, Fang Wang, Xiuying Hu, Min Zhao, Jianhong Yang, Yong Li · 2024 · European Journal of Medicinal Chemistry
  46. Enhancing the anticancer effect of androgen deprivation therapy by monocarboxylate transporter 1 inhibitor in prostate cancer cells
    Jimin Kim, Sanghee Park, Seunghwan Kim, Seungyeon Ryu, Hyemin Hwang, Sua Cho, Yeonju Han, Jisu Kim, Yusun Park, Eun Kyung Lee et al. · 2024 · The Prostate
  47. Beute für das Proteasom: Gezielter Proteinabbau aus medizinalchemischer Perspektive
    Laura Martina Luh, Ulrike Scheib, Katrin Juenemann, Lars Wortmann, Michael Brands, Philipp M. Cromm · 2020 · Angewandte Chemie
  48. Synthesis and evaluation of bifunctional PTP4A3 phosphatase inhibitors activating the ER stress pathway
    Ettore J. Rastelli, Sara Sannino, Duncan J. Hart, Elizabeth R. Sharlow, John Stephen Lazo, Jeffrey L. Brodsky, Peter Wipf · 2021 · Bioorganic & Medicinal Chemistry Letters
  49. Targeted Protein Degradation: Principles, Strategies, and Applications
    Ting He, Chenxi Wen, Guodong Yang, Xuekang Yang · 2023 · Advanced Biology
  50. Inhibition of N‐myristoyltransferase activity promotes androgen receptor degradation in prostate cancer
    Omar Awad Alsaidan, Emmanuel Onobun, Chenming Ye, Lei Lou, Zanna M. Beharry, Zhong‐Ru Xie, Iryna Lebedyeva, David Crich, Houjian Cai · 2023 · The Prostate
  51. Discovery of Norbornene as a Novel Hydrophobic Tag Applied in Protein Degradation
    Shaowen Xie, Feiyan Zhan, Jingjie Zhu, Yuan Sun, Huajian Zhu, Jie Liu, Jian Chen, Zheying Zhu, Dong‐Hua Yang, Zhe‐Sheng Chen et al. · 2023 · Angewandte Chemie
  52. A host–guest approach to ratiometric pH sensing using upconversion nanoparticles
    Ivo Rosenbusch, Marylyn Setsuko Arai, Fabio Rizzo, Andréa Simone Stucchi de Camargo, Bart Jan Ravoo · 2025 · Nanoscale Advances
  53. Expanding the targeted protein degradation approach with small molecule chimeras directed to the 26S proteasome
    Mireia Casasampere, Héctor Carneros, Tania Roda Carrera, Alice Zuin, Núria Gallisà-Suñé, Alba Gonzalez-Artero, Bernat Coll-Martínez, José Luis Abad, Abdulateef Alqahtani, Josefina Casas et al. · 2026 · Nature Communications
  54. Rational Design, Synthesis, and Biological Evaluation of Novel c-Met Degraders for Lung Cancer Therapy
    Xingyang Qiu, Qingquan Zheng, Dongdong Luo, Yue Ming, Tingting Zhang, Wenchen Pu, Min Ai, Jianhua He, Yong Peng · 2025 · Journal of Medicinal Chemistry
  55. Discovery of novel biphenyl derivatives as androgen receptor degraders for the treatment of enzalutamide-resistant prostate cancer
    Wenqiang Zhang, Yawen Fan, Yan Zhang, Yunrui Feng, Yi Luo, Xiaoyu Zhou, Zhuolin Chen, Chenxiao Wang, Tao Lu, Feng Tang et al. · 2024 · Bioorganic Chemistry
  56. Aptamer-Hytac Chimeras for Targeted Degradation of SARS-CoV-2 Spike-1
    Carme Fàbrega, Núria Gallisà-Suñé, Alice Zuin, Juan Sebastián Ruíz, Bernat Coll-Martínez, Gemma Fabriàs, Ramón Eritja, Bernat Crosas · 2024 · Cells
  57. Mechanisms and Design Principles of Proteolysis-Targeting Chimeras and Their Emerging Applications
    Nikola Knoll, Nouri Neamati, Aykut Üren · 2026 · ACS Pharmacology & Translational Science
  58. Selective Protein Degradation through Tetrazine Ligation of Genetically Incorporated Unnatural Amino Acids
    Jinghao Chen, Gaocan Dai, Shixiang Duan, Yang Huang, Yi‐Lin Wu, Zhi Xie, Yu‐Hsuan Tsai · 2024 · Chemistry - An Asian Journal
  59. Design, synthesis and biological evaluation of novel tubulin-targeting agents with a dual-mechanism for polymerization inhibition and protein degradation
    Sibo Wang, Jiahao Wang, Xiankun Lu, Meitong Liu, Yue Liu, Mi Li, Xuejie Kong, Lan Wu, Qi Guan, Weige Zhang · 2024 · European Journal of Medicinal Chemistry
  60. Site‐Selective Aryl Diazonium Installation onto Protein Surfaces at Neutral pH using a Maleimide‐Functionalized Triazabutadiene
    Nicholas D. J. Yates, Natasha E. Hatton, Martin A. Fascione, Alison Parkin · 2023 · ChemBioChem
  61. Discovery of a Structurally Unique Small Molecule that Inhibits Protein Synthesis.
    Durga Thakral, Hyun Seop Tae · 2017 · PubMed Central
  62. Diversified design strategies for small-molecule PROTACs: How do we select?
    Qingsong Chen, Jian-Hua Liang · 2026 · European Journal of Medicinal Chemistry
  63. Bringing Silicon to Drugs: Modular Construction of Sila-Pharmacophores for the Development of Target Protein Degraders
    Zhigang Wu, Xujiang Zhu, Y Li, Xia Wang, Meizhen Huang, Zhenyuan Dong, Jiangnan Zheng, Ruijun Tian, Chuan He, Jie Wang · 2026 · Journal of the American Chemical Society
  64. Synergistic Enhancement of Hydrophobic Tag with Low‐Temperature Photothermal Technique for Cancer Therapy
    Hegang Lu, Junhao Lian, Yunjian Yu, Feihe Ma, Meihui Su, Youtao Xin, Yuanchu Jin, Luyi Zhang, Mahmoud Elsabahy, Hui Gao · 2025 · Small
  65. The Production of Second-generation Bioethanol from Lignocellulosic Biomass using Two Strains of Sacharomyces cerevisiae
    Majekodunmi Racheal Adedayo, FE Adetula, Adeyinka Elizabeth Ajiboye, Bashirat Olamide Yusuf-Salihu · 2022 · Journal of Advances in Microbiology
  66. RECENT ADVANCES IN TARGETING THE ANDROGEN RECEPTOR WITH PROTACS
    Weiguo Xiang, Xin Han, Lijie Zhao, Shaomeng Wang · 2022 · Medicinal chemistry reviews
  67. Selective Degradation of Polo‐like Kinase 1 by a Hydrophobically Tagged Inhibitor of the Polo‐Box Domain
    Stefan Rubner, Andrej Scharow, Sabine Schubert, Thorsten Berg · 2018 · Angewandte Chemie
  68. Design, synthesis, and biological evaluation of ML162-based glutathione peroxidase 4 (GPX4) degraders with hydrophobic tags
    Yao Ning, Yi‐Cheng Wang, Huan Liu, Jing Wang, Zeqi Zhu, Yanhua Sun, Xue Qiu, Yong Wang · 2025 · European Journal of Medicinal Chemistry
  69. Identification of N-tert-butyloxycarbonyl protected amino acids as novel hydrophobic tags to induce targeted protein degradation
    Hui Sun, Xueyi Luo, Honggang Hu, Cong Li, Cheng Lyu, Zeming Lin, Cong Wang, Xin Chen, Hao Jiang, Ping Xu et al. · 2025 · European Journal of Medicinal Chemistry
  70. Darwinian Selection in Prostate Cancer and Medical Treatment
    Chunjiao Song · 2017 · International Journal of Clinical Medicine
  71. Discovery of novel spirocyclic derivates as potent androgen receptor antagonists
    Wenqiang Zhang, Xiaoyu Zhou, Hao‐Jie Zhu, Yawen Fan, Zhuolin Chen, Chenxiao Wang, Xingru Chen, Hongmei Li, Tao Lu, Xian Wei et al. · 2025 · Bioorganic & Medicinal Chemistry
  72. The role of vitamin C on the skin
    Lehlohonolo Makhakhe · 2025 · South African Family Practice
  73. Development of Adamantane-based hydrophobic tags targeting anaplastic lymphoma kinase with enhanced antitumor activities
    Jingjie Zhu, Fangyi Zhan, Jia Xie, Tonghao Fang, Yuan Sun, Feiyan Zhan, Tian Xiang Gao, J. Y. Liu, Jiajie Feng, Pijun Zhou et al. · 2025 · Bioorganic Chemistry
  74. Structural optimization of AR and AR-V7 degraders incorporating silicon-based hydrophobic tags for treatment of castration-resistant prostate cancer
    Lei Xu, Mengmeng Wang, Yanshuo Cheng, Hanhan Kuang, Yijing Zhu, Ning Liu, Jiefu Wang, Shicong Li, Jiefu Wang, Junfeng Wang et al. · 2026 · European Journal of Medicinal Chemistry
  75. Advances in AR-Targeting Chimeras: A Case Study of proteolysis-targeting Chimeras From Bench to Bedside
    Wu Du · 2022 · Future Medicinal Chemistry
  76. Androgen Receptor Ligands: Agonists and Antagonists
    Folake A. Orafidiya, Amy E. Monaghan, Iain J. McEwan · 2017 · Elsevier eBooks
  77. Targeted Protein Degradation by Proteolysis Targeting Chimeras
    Wu Du · 2022 · Wiley eBooks
  78. Bifunctional proximity-inducing strategies for targeted and programmable post-translational modifications
    Sadiya Tanga, Pallabi Das, Tuhin Baran Samoi, Arpita Hota, Arkadeep Karmakar, Basudeb Maji · 2026 · Advanced Drug Delivery Reviews
  79. Ubiquitin receptor–mediated, ubiquitin-independent targeted protein degradation via 26 S proteasomes
    Seh Hoon Park, Yejin Jang, Soo-Yeon Lee, Eunseo Kim, Dawon Jeong, Insuk Byun, Jiseong Kim, Jisoo Yang, Chang‐Han Lee, Dohyun Han et al. · 2026 · Science Advances
  80. PROTACs in the Management of Prostate Cancer
    Deepa S. Mandlik, Satish K. Mandlik · 2024 · Springer eBooks
  81. Harnessing hydrophobic tag technology to combat drug-resistant influenza: design, synthesis and potency of oseltamivir-derived HyTTDs
    Yongqing Liu, Haobin Li, Dizhen Liang, Yuanguang Chen, Kunyu Lu, Hongqi Tao, Yuanmei Wen, Fan Pan, Xumu Zhang, Shuwen Liu et al. · 2025 · New Journal of Chemistry
  82. Discovery of Novel Bifunctional Agents as Potent Androgen Receptor Antagonists and Degraders for the Treatment of Enzalutamide-Resistant Prostate Cancer
    Wenqiang Zhang, Hao‐Jie Zhu, Zhuolin Chen, Hongmei Li, Xingru Chen, Yawen Fan, Xiaoyu Zhou, Yi Luo, Yan Zhang, Feng Shii Tang et al. · 2025 · Journal of Medicinal Chemistry
  83. Repurposing a DNA‐Repair Enzyme for Targeted Protein Degradation
    Callie Fredlender, Samantha R. Levine, Jan Zimak, Robert C. Spitale · 2022 · ChemBioChem
  84. Cancer Targets Involving the Ubiquitin Proteasome System
    Erika M. V. Araujo · 2021 · Wiley eBooks
  85. Idegenerering i IT-bedrifter - åpenhet og nettverks betydning for idégenerering
    Tony Andreas Liafjell · 2014 · NORA - Norwegian Open Research Archives
  86. New Therapeutic Chemical Modalities: Compositions, Modes-of-action, and Drug Discovery
    Eric Valeur · 2023 · Royal Society of Chemistry eBooks
  87. Androgen receptor degraders as antiprostate cancer agents
    Qiao‐Hong Chen · 2025 · Elsevier eBooks
  88. Androgen Receptor Ligands: Agonists and Antagonists
    Folake A. Orafidiya, Amy E. Monaghan, Iain J. McEwan · 2025 · Elsevier eBooks
  89. Protease-mediated degradation
    Lu Yang, Haiting Duan, Xinfei Mao, Bizhi Li, Jinxin Che, Xiaowu Dong · 2025 · Elsevier eBooks
  90. Thyroid hormone receptor beta signaling is a targetable driver of prostate cancer growth
    Aleksandra Fesiuk, Daniel Pölöske, Elvin D. de Araujo, Geordon A. Frere, Timothy B. Wright, Gary Tin, Yasir S. Raouf, Olasunkanmi O. Olaoye, Ji Sung Park, Nicolas Blavet et al. · 2025 · Molecular Cancer
  91. Design, synthesis, and biological evaluation of hydrophobic-tagged poly (ADP-ribose) polymerase 1 (PARP1) degraders
    Jiaqian Li, Yang Cui, Mengyu Xiong, Liying Zhang, Shuo Mu, Ziqi He, Hongcheng Zhu, Kaiyin Yang, Qidi Zhong · 2026 · Bioorganic Chemistry
  92. PDE1B and PDE10A as novel targets for schizophrenia: from molecular design and synthesis to therapeutic promise
    Jaya Rautela, Anand Gaurav, Veeranoot Nissapatorn, Chung Keat Tan, Ana Paula Girol, Maria de Lourdes Pereira, Vannajan Sanghiran Lee · 2026 · Frontiers in Pharmacology
  93. Reprogramming Aromatic Camptothecins into TOP1 Degraders via Synergistic Hydrophobic Tagging and Supramolecular Assembly
    Chunwei Shan, Qian Chen, Xixian Sun, Shangjiu Hu, Thulasiram Bathini, Zijiang Yang, Kaiming Chen, Shan Mou, Ruowen Wang, Weihong Tan · 2026 · Journal of the American Chemical Society
  94. Artemisinin-derived hydrophobic tags: structural modification and structure-activity relationship exploration of HDAC6/1 targeting degraders with potent antileukemic efficacy
    Changqi Wang, Qiying Yu, Xing Lu, Yuanli Yang, Yuanyuan Li, Xiong Sun, Huan He, Silong Zhang, Hang Zhong · 2026 · Bioorganic Chemistry
  95. Development of Hydrophobic Tag Based HDAC6 Degrader for Ulcerative Colitis Treatment
    Daoran Lu, Rongfeng Liu, Congcong Zheng, Yueyi Sun, Jianjun Gao, Yepeng Luan · 2026 · Journal of Medicinal Chemistry
  96. PROTAC-Based Strategies in Neurodegenerative Diseases: Challenges and Perspectives
    Pasquale Degennaro, Imane Ghafir El Idrissi, Rosa Purgatorio, Annalisa Fanizzi, Mariagrazia Rullo, Leonardo Pisani, Eleonora Macchia, Luisa Torsi, Angela Stefanachi, Francesco Leonetti · 2026 · Pharmaceuticals
  97. Light-Triggered Decoding of Hydrophobic Interactions in Living Systems
    Peng Ji, Stormi R. Chadwick, Alexander Harjung, Wei‐An Chen, Neal K. Devaraj · 2026 · Journal of the American Chemical Society
  98. Hydrophobic Tag Protein Degraders: An Emerging Therapeutic Strategy for Cancer
    Tania Aguilera Pineda, Siddhartha Kumar, Gargi Ghosal, Amarnath Natarajan, Adam R. Karpf · 2026 · Pharmaceuticals
  99. BindingDB Entry 50016950: Therapeutic Strategies to Target the Androgen Receptor.
    BindingDB · 2023 · UC San Diego
  100. BindingDB Entry 50012748: A critical update on the strategies towards modulators targeting androgen receptors.
    BindingDB · 2022 · UC San Diego